[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342390-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342390-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","transcriptomic-insights-into-utuc-role-of-inflammatory-fibrosis-and-potential-for-personalized-treatment","Transcriptomic insights into UTUC - role of inflammatory fibrosis and potential for personalized treatment","","Upper tract urothelial carcinoma (UTUC) is a rare urothelial cancer with a higher metastasis propensity than bladder cancer (BC) despite overlapping non-surgical therapies and broadly similar molecular mechanisms. This study analyzes transcriptomic differences between UTUC and BC to clarify drivers of UTUC’s aggressive metastatic behavior, develop and validate a metastasis/prognosis model, and propose personalized treatment strategies based on drug screening and functional validation.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/transcriptomic-insights-into-utuc-role-of-inflammatory-fibrosis-and-potential-for-personalized-treatment/342390/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/transcriptomic-insights-into-utuc-role-of-inflammatory-fibrosis-and-potential-for-personalized-treatment/342390.png","ImageObject",300,407,{"name":42,"@type":43},"Jiven","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main focus of the study on UTUC?","Question",{"text":63,"@type":64},"The study examines transcriptomic differences between UTUC and bladder cancer to explain UTUC’s higher metastatic tendency and to build a prognosis and metastasis model.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which biological pathway-related feature is highlighted in the results?",{"text":68,"@type":64},"Inflammatory fibrosis is identified as a key factor, including reductions in extracellular matrix and cell adhesion molecules linked to proteoglycan regulation in UTUC versus BC.",{"name":70,"@type":61,"acceptedAnswer":71},"How do the authors propose personalized treatment for UTUC?",{"text":72,"@type":64},"The work suggests UTUC patients may achieve better prognosis by combining tyrosine kinase inhibitors (TKIs) with conventional gemcitabine and cisplatin chemotherapy.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342390,1790151020,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":128,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","Li et al. Journal of Translational Medicine (2024) 22:24  \n[https://doi.org/10.1186/s12967-023-04815-y](https://doi.org/10.1186/s12967-023-04815-y)  \nJournal of Translational Medicine  \n RESEARCH Open Access  \nTranscriptomic insights into UTUC:  \nrole of inflammatory fibrosis and potential for personalized treatment  \nKeqiang Li 1,2† , Zhenlin Huang1†, Guoqing Xie1,2†, Budeng Huang1,2†, Liang Song1,2, Yu Zhang1,2* and Jinjian Yang1*  \nAbstract  \nBackground Upper tract urothelial carcinoma (UTUC) is a rare disease, belonging to the same category of urothelial cancers as bladder cancer (BC) . Despite sharing similar non-surgical treatment modalities, UTUC demonstratesa higher metastasis propensity than BC. Furthermore, although both cancers exhibit similar molecular disease emergence mechanisms, sequencing data reveals some differences. Our study investigates the transcriptomic distinctions between UTUC and BC, explores the causes behind UTUC’s heightened metastatic tendency, constructs a model for UTUC metastasis and prognosis, and propose personalized treatment strategies for UTUC.  \nMethods In our research, we utilized differential gene expression analysis, interaction networks, and Cox regression to explore the enhanced metastatic propensity of UTUC. We formulated and validated a prognostic risk model using diverse techniques, including cell co-culture, reverse transcription quantitative polymerase chain reaction (rt-qPCR), western blotting, and transwell experiments. Our methodological approach also involved survival analysis, risk model construction, and drug screening leveraging the databases of CTRPv2, PRISM and CMap. We used the Masson staining technique for histological assessments. All statistical evaluations were conducted using R software and GraphPad Prism 9, reinforcing the rigorous and comprehensive nature of our research approach.  \nResults Screening through inflammatory fibrosis revealed a reduction of extracellular matrix and cell adhesion molecules regulated by proteoglycans in UTUC compared with BC, making UTUC more metastasis-prone. We demonstrated that SDC1, LUM, VEGFA, WNT7B, and TIMP3, are critical in promoting UTUC metastasis. A risk model based on these five molecules can effectively predict the risk of UTUC metastasis and disease-free survival time. Given UTUC’s unique molecular mechanisms distinct from BC, we discovered that UTUC patients could better mitigate the issue of poor prognosis associated with UTUC’s easy metastasis through tyrosine kinase inhibitors (TKIs) alongside the conventional gemcitabine and cisplatin chemotherapy regimen.  \nConclusions The poor prognosis of UTUC because of its high metastatic propensity is intimately tied to inflammatory fibrosis induced by the accumulation of reactive oxygen species. The biological model constructed using the five  \n†Keqiang Li, Zhenlin Huang, Guoqing Xie and Budeng Huang contributed equally to this work and share first authorship.  \n*Correspondence:  \nYu Zhang [william19940918@outlook.com](william19940918@outlook.com)[ ](william19940918@outlook.com)Jinjian Yang  \n[hzlinok@126.com](hzlinok@126.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. ","cbCaiakSr24aRWkC","https://ap.wps.com/l/cbCaiakSr24aRWkC","pdf",5814576,"English","# Abstract\n# Methods\n# Results\n# Conclusions\n# Keywords\n# Introduction","[{\"question\":\"What is the main focus of the study on UTUC?\",\"answer\":\"The study examines transcriptomic differences between UTUC and bladder cancer to explain UTUC’s higher metastatic tendency and to build a prognosis and metastasis model.\"},{\"question\":\"Which biological pathway-related feature is highlighted in the results?\",\"answer\":\"Inflammatory fibrosis is identified as a key factor, including reductions in extracellular matrix and cell adhesion molecules linked to proteoglycan regulation in UTUC versus BC.\"},{\"question\":\"How do the authors propose personalized treatment for UTUC?\",\"answer\":\"The work suggests UTUC patients may achieve better prognosis by combining tyrosine kinase inhibitors (TKIs) with conventional gemcitabine and cisplatin chemotherapy.\"}]","Transcriptomic insights into UTUC - role of inflammatory fibrosis and potential for personalized treatment | PDF",1790046398,48,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9f1ab8051dfc8357c201431984062688.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7f18918dc5b5a3629aa443976753fc77.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/09fe174f8ca31ac94978ee1861b90680.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/28ae98fad5cd6241e84e1cb65f3b4d7d.webp",980,1301]